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ABSTRACT The class I genes of the nuijor hlstocompati-
bllity complex of the mouse can be divided into two categories: 
those encoding the transplantation antigens and those encoding 
the Qa and Tla antigens. The inbred BALB/c mouse has 28 
potendal Qa/Tis genes. The sites of tissne expression, devel-
opmental regulation, and functions of these genes are virtually 
unknown. We have used the technique of exon shuffling to 
construct hybrid genes between each of three Qa ~n genes 
(QS, Q7, and QB) and two other class I genes (H-2L and Q6). 
The hybrid genes have been transfected into mouse L cells, in 
which intact transplantation antigen genes generally are ex-
pressed and in which intact Qa genes generally are not 
expressed. Analysis of expression of the hybrid gene constructs 
indicates that the 5' half of two of the Qa genes (QS and QB) can 
readily be expressed in the context of a hybrid molecule, 
whereas the 3' half prevents cell-surface expression. The e:xon 
shuffling approach described here will be useful in character-
izing Qa/Tis genes and in identifying or producing new 
reagents to study the Qa/Tis gene products, their tissne 
distribution, their developmental stages of expression, and, 
ultimately, their functions. 
The major histocompatibility complex (MHC) of the mouse 
is a multigene complex on chromosome 17 that encodes a 
number of cell-surface proteins that play an important role in 
the regulation of the immune responses (for recent review, 
see ref. 1). MHC products include class I molecules encoded 
by the H-2 and Qa/Tla regions. The H-2 class I proteins, or 
transplantation antigens, are extremely polymorphic mole-
cules expressed on most somatic cells. The H-2 molecules 
participate in recognition and destruction of virus-infected or 
neoplastically transformed cells by cytotoxic T lymphocytes. 
The class I molecules encoded by the Qa/Tla complex are 
much less polymorphic and have a limited tissue distribution, 
usually restricted to hematopoietic cells (2-4). They have 
been identified through alloreactive cytotoxic reactions and 
by biochemical and serological methods. The functions of 
Qa/Tla molecules are not known. The two types of class I 
proteins are structurally similar. Both have heavy chains of 
38,000-45,000 daltons and are associated noncovalently with 
a 12,000-dalton light chain, ~-microglobulin ~m), encoded 
outside the MHC (1, 5, 6). Inbred strains of mice have distinct 
constellations of MHC alleles denoted by their H-2 haplo-
types. 
Genetic analysis of the MHC of BALB/c (H-2d haplotype) 
mice has indicated that there are 33 genes per haploid 
chromosome set that might potentially encode class I anti-
gens (7-11). Only 5 of these genes map in the H-2 region. The 
remaining 28 have been assigned to the Qa/Tla region, and 10 
of these genes map in the Qa subregion and are denoted 
Ql-QIO. 
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Most of the class I genes consist of eight exons. Exon 1 
encodes the leader sequence; exons 2-4 encode the ah a 2, 
and a 3 external regions; exon 5 encodes the transmembrane 
region; and exons 6-8 encode the cytoplasmic region. The a 1 
and a 2 regions fold to form one external domain and the a 3 
and ~m peptides generate a second membrane proximal 
external domain (12-15). 
When the cloned H-2 genes are transfected into L cells, 
they are expressed and can be identified by serological, 
functional, and biochemical methods. In contrast, the ma-
jority of the Qa/Tla genes introduced into L cells do not 
express cell-surface products detectable with available re-
agents (10). We have recently developed a method that makes 
it possible to study the serological and T -cell recognition 
properties of class I molecules that are not ordinarily ex-
pressed on the surface of the transfected L cells (13). The 
approach involves fusion of the specific exons (1-3) of the Qa 
genes to complementary exons (4-8) of the H-2 transplan-
tation antigen genes (exon shuftling) followed by the 
transfection of the hybrid class I genes into L cells. We have 
demonstrated that the hybrid Qa/H-2 molecules can be 
expressed on the cell surface of the L-cell transfectants and 
that the Qa gene-encoded properties can be characterized in 
this system (13). Based on the serological studies of Q6 
hybrid products, it was proposed that the Q6 gene encodes 
the CR (H-2 crossreactive) antigen (16) expressed mainly on 
peripheral T cells (13). We showed that the Q6 gene carries 
a promoter and leader peptide that can function in L cells. 
The apparent lack of expression of the intact Q6 gene in the 
transfected L cells was mapped to a trait(s) encoded by the 
3' portion of the Q6 gene (13). 
In the present study, we have analyzed three other Qa 
genes (Q5, Q7, and Q8) immediately adjacent to Q6 on 
chromosome 17 (Fig. 1). These genes were chosen for study 
because of their close linkage to the previously studied Q6 
gene. In addition, the similarity in restriction maps between 
the Q5, Q6, and Q7 genes suggested that this cluster may 
represent a family of closely related genes (8). 
MATERIALS AND METHODS 
Materials. Monoclonal antibodies used in this study in-
cluded 28-14-8 (anti-Ld), 20-8-4 (anti-Q6, -Kd, -Kb, -r, -s), 
34-1,2 (anti-Q6, -Dd, -Kd, -Ld, -Kb, -r, -s, -p, -q), 30-5-7 
(anti-Ld, -Dq, -L'I), 34-5-8 (anti-Dd), 34-2-12 (anti-Dd), 81.L 
(anti-Dd, -s, -u), 81.R (anti-Dd, -p, -u), 97.H (anti-Dd, -Kd, -p, 
-u, -v), 97.G (anti-Dd, -Kd, -p, -u, -v), and 11-4 (anti-Kk). The 
sources and reactivities of the monoclonal antibodies are 
described in detail in refs. 10-14 and 17. The origin of the 
cloned Q5, Q6, Q7, Q8, Ld, JYI, and Kd genes is given in refs. 
8 and 10. 
Abbreviations: MHC, major histocompatibility complex; fJlm, ~ 
microglobulin; bp, base pair(s); kb, kilobase(s). 
*Permanent address: Biomedical Sciences Division, University of 
California, Riverside, CA 92521-0121. 
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FIG. 1. Map of H-2 and Qa/Tla complex of BALB/c mice. Cosmid designations are from Steinmetz et al. (8). 
Construction of Hybrid Class I Genes. For construction of 
the hybrid Q5 I L d, Ql I L d, and Q8 I L d genes, two Xba I sites 
conserved in Q5, Q6, Ql, and Q8 were utilized (Fig. 2). One 
of these sites is 414 base pairs (bp) upstream from the protein 
initiation codon in ex on 1, and the other is within the large 
intervening sequence between exons 3 and 4, 409 bp down-
stream from the 3' end of exon 3. The procedure used for 
constructing these hybrid genes has been described for the 
Q6/Ld gene (Fig. 2b) (13). Briefly, a 3-kilobase (kb) Bgl 
II/ BamHI fragment of the Q6 gene derived from clone A 27.1 
(7), which carries exons 1-3 and 926 bp of 5' flanking region, 
was cloned into the BamHI site of pBR322. The resultant 
plasmid 1104-4 was linearized with BamHI, and a 2.4-kb 
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FIG. 2. Exon-intron structure of class I and hybrid class I genes. 
Wavy lines denote pBR322 DNA of the cloning vector. Restriction 
sites: B, BamHI; Bg, Bgl II, H, Hindiii; X, Xba I; B/Bg, hybrid site 
created by ligation of BamHI and Bgl II sticky ends, no longer 
recognized by either enzyme. 
Bam HI fragment carrying the 3' end of H-2L d gene, including 
exons 4, 5, 6, 7, and 8, was inserted to make the Q6/Ldhybrid 
gene. For constructing the Q5/Ld, Ql/Ld, and Q8/Ldhybrid 
genes, the 1.8-kb Xba I fragment containing the 5' end of Q6 
was deleted from the Q6/Ld hybrid construct, and it was 
replaced with the equivalent 1.8-kb Xba I fragment from the 
Q5, Q7, or Q8 genes (Fig. 2). 
For construction of the Q6/ Ql hybrid gene, plasmid 1104-4 
was linearized with BamHI and the 2.7-kb BamHI fragment 
derived from cosmid 19.1 (8) containing the 3' portion of the 
Ql gene was inserted. For construction of the Q6/Q8 hybrid 
gene, plasmid 1104-4 was linearized and the 3.0-kb BamHI 
fragment derived from cosmid 36.2 (8) containing the 3' 
portion of the Q8 gene was inserted. The Q6/Q5 hybrid gene 
was constructed by deleting the 0.3-kb fragment of pBR322 
DNA between the BamHI and Hindiii sites of plasmid 
1104-4, and inserting in its place the 3.7-kb BamHI/Hindiii 
fragment derived from cosmid 46.2 (8) and containing the 3' 
end of the Q5 gene. The identity of each hybrid gene 
construct was checked by restriction enzyme analysis. 
Transfection of Mouse L Cells and Radioimmunoassays. 
Mouse thymidine kinase-negative cells (Ltk-) derived from 
C3H mice (H-2k haplotype) were tninsfected with plasmid 
DNAs as described (12-14, 17). Radioimmunoassays were 
performed as described (12-14, 17). 
Identification of the H-2b QJO Gene in BALB/c Mice. An 
18-base oligodeoxyribonucleotide probe, 3' AGTGTGTAA-
CGACTAGAC 5', complementary to the DNA sequence 
encoding amino acids 285-290 of the H-2b Q10 protein (18, 19) 
and corresponding region of the homologous H-2q class I 
protein (20), was synthesized, radiolabeled, and hybridized 
to 2-JLg amounts of cosmid DNA spotted on nitrocellulose 
filters. 
RESULTS 
Expression of Hybrid Genes QS/Ld, Q7/Ld, and Q8/Ld. The 
strategy for testing the expression capacity of the Qa genes 
is based on the pilot study of exon shuffling between the Q6 
and H-2Ld genes (13). Although the intact Q6 gene is not 
expressed on the surface of mouse L cells after transfection, 
a hybrid gene in which the 5' portion of Q6 (exons 1-3 
encoding the leader peptide and two external regions, a 1 and 
a 2) was fused to the 3' portion (exons 4-8 encoding the a 3 
external, transmembrane, and cytoplasmic regions) of H-
2Dd, H-2Kd, and H-2Ld genes were expressed. To test the 
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Table 1. Reactivity of transfected L cells with monoclonal antibodies directed against transplantation antigens 
Antibody /reactivity 
28-14-8/ 20-8-4/ 34-1-2/ 30-5-7 I 34-5-8/ 34-2-12/ 8l.L/ 8l.R/ 97.H/ 97.G/ 11-4/ 
Transfectant aLd aKd aKdl)dLd aLd al)d ape! al)d al)dLdKd al)dKdLd al)dKdLd aKk 
Q5/Ld 14,556 524 15,276 366 230 328 332 179 144 239 10,768 
Q6/Ld 24,698 35,736 31,944 330 570 504 402 211 152 177 11,426 
Ql/Ld 724 546 718 510 378 456 296 222 141 210 12,840 
QB/Ld 18,960 356 478 350 230 270 424 540 514 1,317 10,320 
Q6/Q5 808 820 934 476 344 404 358 242 322 259 14,230 
Q6/Q7 662 662 498 562 268 368 385 283 204 175 11,872 
Q6/Q8 506 686 480 358 166 422 414 288 151 182 12,816 
JJd 728 332 34,244 296 30,366 6736 16,067 19,354 17,557 16,820 12,796 
Ld 37,948 602 20,672 29,900 296 602 306 5,484 3,655 10,876 6,624 
Kd 886 29,822 30,714 426 304 412 212 1,603 6,888 15,966 12,438 
Ltk+ cells 660 392 384 406 208 452 273 127 122 131 12,888 
Radioimmunoassays on mass cultures oftransfected L cells were performed as described (17). Results are expressed as 1251-labeled protein 
A bound (cpm per 5 x lOS cells). The numbers shown are an average of two experiments, with experimental error being <10% of the values 
shown. 
expression potential of the Q5, Q7, and Q8 genes, two sets of 
hybrid genes were constructed (Fig. 2). 
The Q51Ld, Q61Ld, Q71Ld, and Q81Ld hybrid genes were 
cotransfected into thymidine kinase negative (tk-) mouse L 
cells with the thymidine kinase gene of herpes simplex virus. 
Initially, each transfected culture was analyzed for expres-
sion of determinants reacting with monoclonal antibody 
28-14-8, which recognizes determinants on the arPzm do-
main of the H-2L d antigen (12, 13, 20). The L cells transfected 
with the Q51Ld, Q61Ld, and Q81Ld hybrid constructs bound 
the 28-14-8 antibody, while L cells transfected with Q71Ld 
constructs did not (Table 1). These data suggest that L cells 
transfected with Q5lf-d, Q61Ld, and Q81Ld hybrid genes 
expressed membrane-bound hybrid protein products, while 
cells transfected with Q7 I L d gene did not. Formally, we 
cannot exclude the possibility that fusion of the Q7 a 1-a2 
domain to the L d carboxyl terminus has distorted poly-
morphic determinants on the arPzm domain and rendered it 
undetectable to the 28-14-8 antibody. This interpretation, 
however, appears unlikely in view of the apparent 
conformational independence of a 1-a2 and cirf32m domains 
of class I molecules (12, 13, 20-22). We also screened mass 
cultures of the Q51Ld, Q61Ld, Q71Ld, and Q81Ld transfect-
ants with a panel of monoclonal antibodies directed against 
H-2d transplantation antigens (Table 1). The results of these 
experiments and the results obtained with cloned lines of 
these transfectants (Fig, 3) revealed that Q5 I L d hybrid gene 
products bound monoclonal antibody 34-1-2 in addition to 
monoclonal antibody 28-14-8, and that the Q81Ld antigen 
crossreacted weakly with monoclonal antibody 97.G (23). 
Since the stability of the expression of hybrid genes in the 
transfectants is not known, we cannot derive a quantitative 
estimate of the degree to which the different molecules 
crossreacted with the antibodies tested. Typically, cells 
transfected with the Q5 I L d construct bound antibodies 
28-14-8 ~d 34-1-2 at a lower saturatiot:~ level than cells 
transfected with the L d and IY' genes. In addition, the dilution 
curves for reaction of the 97.G antibody with the Q81Ld 
hybrid gene product were shifted approximately one order of 
magnitude toward higher antibody concentrations relative to 
dilution curves obtained with the Dd antigen. The results are, 
however, unambiguous in showing that 34-1-2 and 97.G 
antibodies react with the Q51Ld product and the Q81Ld 
product, respectively. Previous results have indicated that 
the 34·1-2 antibody reacts with the a 1-a2 domain ofLd, Dd, 
Kd, and Q6 antigens (13, 20) and that the 97 .G antibody reacts 
with the a 1-a2 domain of the Dd molecule (14). Therefore, it 
is likely that these two antibodies react with the a 1-a2 domain 
of the Q51Ld and Q81Ld hybrid antigens. 
As a control for these experiments, three hybrid genes 
were constructed in wnich the Xba I fragments covering the 
5' end of the Q5, Q7, and Q8 genes were cloned in the inverted 
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FIG. 3. Results of radioimmunoassays (average of two experi-
ments) on cloned cell lines transfected with hybrid genes, transplan-
tation antigen genes, and intact Qa genes. Monoclonal antibodies 
used in titration experiments were 28-14-8 (a and c), 34-1-2 (b), and 
97.G (d). 
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orientation in combination with the 3' end of the Ld gene. 
These control hybrid genes would not be predicted to code 
for a class I protein product because they have an inversion 
including the promoter region and the frrst three exons. 
Mouse L cells transfected with these control hybrid genes did 
not in any case bind the 28-14-8 antibody (results not shown). 
Therefore, exyression of the L d antigenic determinant by the 
Q5 I L d, Q61 L , and Q81 L d hybrid genes was dependent on the 
introduction of a complete gene with all coding regions in the 
proper order and orientation. Expression of the transfected 
gene was thus apparently not attributable to recombination 
with class I genes of the recipient mouse L cells (17). Our 
overall results are consistent with the interpretation that the 
Q5 arid Q8 genes, like the Q6 gene (13), encode promoters, 
leader peptides, and a 1-a2 domains that are functional in L 
cells, although we cannot absolutely exclude the possibility 
that the Q6 gene contributed an upstream control element 
distal to the first Xba I site at position -414. 
Expression of Hybrid Genes Q6IQ5, Q6IQ7, and Q6IQ8. 
The second set of hybrid genes was constructed by recom-
bination of the 5' portion of the Q6 gene with 3' portions of 
the other Qa genes (Fig. 2). We chose these particular 
combinations because it has been demonstrated previously 
that fusion of the NHrterminal portion of the Q6 molecule to 
the COOH terminus of the Kd, L d, and Dd molecule did not 
distort determinants located on the a 1-a2 domain of Q6 and 
did not alter their recognition by monoclonal antibodies 
20-8-4 and 34-1-2 (13). Therefore, determinants located in the 
a 1-a2 domain of Q6 appear to be fairly independent of 
interaction with other arf32m domains. 
The hybrid genes were transfected into L cells, and the 
transfectants were screened with the panel of monoclonal 
antibodies shown in Table 1. None of the three new con-
structs produced a protein product on the surface of the L 
cells that reacted with the 20-8-4 or 34-1-2 antibodies, or any 
of the other anti-H-2d monoclonal antibodies tested. To 
demonstrate that the p1104.4 vector used in construction of 
the hybrid genes was intact, a control experiment was 
performed in which the 3' end of the L d gene was cloned into 
the same DNA preparation of plasmid 1104-4 used for 
constructing the Q6IQ5, Q61Q7, and Q61Q8 hybrids. The 
reconstructed Q61Ld hybrid gene was transfected into L 
cells. The resultant transfectants strongly bound the 20-8-4 
and 34-1-2 antibodies, indicating that the reconstructed 
Q6 I L d hybrid gene was functional. These results indicate that 
the 3' portions of the Q5, Q7, and Q8 genes, like the 3' portion 
of the Q6 gene, contain some feature(s) that prevent the 
display of their products on the surface ofL cells. Consistent 
with this interpretation are the results of the screening of Q5 
and Q8 gene transfectants with monoclonal antibodies 34-1-2 
and 97.G (Fig. 3). These determinants, shown to be encoded 
by the a 1-a2 domain of Q5 and Q8, are not detectable on the 
cell surface of L cells transfected with the intact parental 
genes. This result is attributed to the presence of the 3' 
portion of these genes. 
. ldeiltif1C8tion of tbe H-26 QJO Equivalent in BALBic Mice. 
Mellor et al. (24) have recently characterized a nonpolymor-
phic class I gene (H-2b QJO) from C57BLI10 (H-2b haplotype) 
mice that maps to the Qa region. Its sequence is generally 
homologous to transplantation antigen genes but contains an 
unusual exon 5. This region, which in transplantation anti-
gens encodes the transmembrane region, contains codons for 
three polar amino acids and a premature termination codon 
(24), which would interfere with its insertion into the plasma 
membrane. The product ofthis gene appears to be a secreted, 
truncated class I-like protein that is produced primarily in the 
liver (24-27). Based on restriction maps, Mellor et al. (24) 
suggested that the H-2b QIO gene may be similar to the gene 
in cosmid cluster 9 of the H-2d haplotype (H-2d Q8). To 
test whether the gene in cosmid cluster 9 is in fact the H-2d 
Proc. Natl. Acad. Sci. USA 82 (1985) 
haplotype equivalent of the H-2b QIO gene, an 18-base 
oligonucleotide probe specific for exon 5 of the H-2b QIO gene 
was synthesized and hybridized with DNAs from cosmids 
isolated from H-2d mice covering the entire Qa region (ref. 8; 
Fig. 1). Very strong hybridization was obtained with the 
cluster 9 cosmid 36.2 but not with any of the other cosmids 
(results not shown). The result indicates that the Q8 gene in 
cluster 9 corresponds to the H-2b QJO gene. 
DISCUSSION 
The MHC ofBALBic mouse encOdes 33 class I genes (7-11). 
The functions of three of these, the H-2K, -D, and -L 
molecules, are known at least in part. Several interesting 
questions remain concerning the other 30 class I genes. First, 
how many can be expressed as polypeptides? Alternatively, 
how many are pseudogenes? Second, in what tissues and 
during which stages of development are these genes ex-
pressed? Finally, what functions are encoded by the noil-H-2 
class I genes? The approach described here of exon shutiling 
between non-H-2 class I genes and a class I H-2 gene whose 
expression capacity is established will be extremely useful in 
exploring the coding capacities, tissue-specific regulatory 
elements, and ultimately the functions of these genes. 
The present experiments extend previous expression stud-
ies on the Q6 gene (13) to three genes closely linked to Q6: 
Q5, Q7, and Q8. Using the same approach of exon shuftling 
and L-cell transfection, we demonstrate that the strategy 
used to characterize the Q6 gene product can be applied to 
other class I genes and allows a definition of their serological 
and T -cell recognition properties. Our results show that three 
of four of the Qa region genes carry promoter elements and 
leader peptides that are functional in L cells and that the 
a 1-a2 external domains encoded by these genes can be 
expressed as structurally stable components of hybrid class 
I proteins. These data are consistent with the supposition that 
at least three of the Qa genes are functional. Constructs 
containing the 5' or 3' portions of the fourth Qa gene, Q7, are 
not expressed in L cells. The H-2d Q7 gene has been proposed 
to have arisen as a fusion product of two genes in the H-2b 
haplotype (H-2b Q8 and H-2b Q9) (18). The apparent lack of 
expression of this gene in transfection experiments suggests 
the possibility that the fusion may have generated a pseudo-
gene. 
In the present stud)', we have identified the gene in cosmid 
cluster 9 as the H-2 haplotype equivalent of the H-2b QJO 
gene (18, 19, 24-27). This gene appears to be very highly 
conserved among different strains of mice (24). The sequence 
analysis of the H-2b QIO gene compared with a eDNA 
sequence derived froiD H-2q haplotype revealed only seven 
nucleotide substitutions out of 1368 bp (24). Therefore, one 
feature residing in the 3' portion of the homologous H-2d Q8 
gene that interferes with expression on the surface of L cells 
is very likely a transmembrane region that cannot insert into 
the plasma membrane .. 
On the other hand, the Q6 gene was proposed to encode a 
cell-surface molecule whose lack of expression on L cells is 
caused by a requirement for tissue-specific factors missing in 
fibroblasts (13). This explanation is based on theoretical 
calculations of the hydrophobicity values for the trans-
membrane and cytoplasmic regions of the Q6 molecule, and 
on serological resemblance of Q6 hybrid proteins to the CR 
(H-2 crossreactive) antigen (16) found normally on the 
surface of some T cells and B cells. Thus, although all four 
Qa genes have some feature at the 3' end that prevents 
expression on the surface of L cells, the molecular mecha-
nisms for this phenomenon may differ. In analogy with the Q6 
and Q8 genes, some of these genes might code for secreted 
proteins while others might be cell-surface antigens restricted 
in expression to certain tissues. DNA sequence analysis of 
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Q5 and Q7 as well as other Qa/Tla genes is necess~ in order 
to gain further insights into the expression potential and 
possible function(s) of this family of genes. 
Serological characterization of the Q5 and Q8 antigens 
revealed that the a 1-a2 domains encoded by these genes 
contain determinants recognized by antibodies directed 
against polymorphic regions ofH-2d transplantation antigens. 
These observations further support the hypothesis that the 
external domains of the Qa/Tla gene products are structur-
ally similar to transplantation antigens. It remains to be 
determined whether the Q5 and Q8 molecules can carry out 
any of the known functions of the transplantation antigens 
(e.g., induction of T-cell proliferation or presentation of 
antigens to cytotoxic T cells), or if, as proposed by Kress et 
a/. (26) for secreted class 1-like molecules, they can block 
interactions ofT-cell receptors with other target molecules. 
The a 1-a2 domains of the Q5, Q6, and Q8 hybrid antigens 
exhibit different patterns of reaction with the panel of 
anti-H-2d monoclonal antibodies, indicating differences in 
antigenic determinants. It will be possible to use L cells 
transfected with the Qa/Ld hybrid genes to generate new 
monoclonal antibodies directed against the a 1-a2 domains of 
the Qa antigens. These antibodies can then be used to screen 
different tissues and cells in various stages of embryogenesis 
and differentiation to find the cells expressing the Qa anti-
gens. This approach may provide clues to the role of the 
Qa/Tla region genes in cell-cell interactions. 
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